BioNTech raises US$250m from investors including Temasek

[FRANKFURT] BioNTech said Singapore's investment company Temasek and other investors are injecting US$250 million into the German biotech firm through a private placement.

The company, which is developing a Covid-19 vaccine, said the transaction includes the purchase of about US$139 million in ordinary shares and a US$112 million investment in four-year mandatory convertible notes.

REUTERS